Differential response of vascular smooth muscle cells to oxidized LDL in mouse strains with different atherosclerosis susceptibility

被引:21
作者
Miyoshi, Toru
Jing, Tian
Matsumoto, Alan H.
Shi, Weibin [1 ]
机构
[1] Univ Virginia, Dept Radiol, Charlottesville, VA 22908 USA
[2] Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA
关键词
vascular smooth muscle cell; atherosclerosis; lipoprotein; mice;
D O I
10.1016/j.atherosclerosis.2005.12.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oxidized low-density lipoprotein (LDL) has numerous atherogenic properties, including induction of inflammatory genes, and vascular smooth muscle cells (VSMC) are involved in the development of atherosclerosis. In this study, we examined whether variations of VSMC in the capacity to oxidize LDL or in response to minimally modified LDL (MM-LDL) constitute a genetic component in atherosclerosis. VSMC were isolated from the aorta of two inbred mouse strains C57BL/6J (136) and C3H, which differ markedly in susceptibility to atherosclerosis. LDL oxidation was assessed by measuring thiobarbituric acid-reactive substance (TBARS) production. Responses to MM-LDL were evaluated by examining the expression of inflammatory genes involved atherosclerosis, including monocyte chemotactic protein-1 (MCP-1) and vascular cell adhesion molecule-1 (VCAM-1), and an oxidant stress gene, heme oxygenase-1 (HO-1). VSMC from the two strains exhibited a comparable ability to transform native LDL to oxidized LDL, whereas their response to MM-LDL differed markedly. MM-LDL resulted in dramatic induction of MCP-1, VCAM-1, and HO-1 mRNAs in the cells from B6 mice but exerted little effect in cells from C3H mice. MCP-1 and soluble VCAM-1 protein levels in conditioned media were measured by ELISA. B6 cells produced significantly more MCP-1 and VCAM-1 proteins in response to MM-LDL than C3H cells. These data suggest that variation in the response of VSMC to oxidized LDL may contribute to the difference between B6 and C3H mice in atherosclerosis susceptibility. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:99 / 105
页数:7
相关论文
共 27 条
[1]   Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice [J].
Aiello, RJ ;
Bourassa, PAK ;
Lindsey, S ;
Weng, WF ;
Natoli, E ;
Rollins, BJ ;
Milos, PM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (06) :1518-1525
[2]   α4β1 integrin (VLA-4) blockade attenuates both early and late leukocyte recruitment and neointimal growth following carotid injury in apolipoprotein E (-/-) mice [J].
Barringhaus, KG ;
Phillips, JW ;
Thatte, JS ;
Sanders, JM ;
Czarnik, AC ;
Bennett, DK ;
Ley, KF ;
Sarembock, IJ .
JOURNAL OF VASCULAR RESEARCH, 2004, 41 (03) :252-260
[3]   MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN INDUCES MONOCYTE CHEMOTACTIC PROTEIN-1 IN HUMAN ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE CELLS [J].
CUSHING, SD ;
BERLINER, JA ;
VALENTE, AJ ;
TERRITO, MC ;
NAVAB, M ;
PARHAMI, F ;
GERRITY, R ;
SCHWARTZ, CJ ;
FOGELMAN, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) :5134-5138
[4]   A major role for VCAM-1, but not ICAM-1, in early atherosclerosis [J].
Cybulsky, MI ;
Iiyama, K ;
Li, HM ;
Zhu, SN ;
Chen, M ;
Iiyama, M ;
Davis, V ;
Gutierrez-Ramos, JC ;
Connelly, PW ;
Milstone, DS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (10) :1255-1262
[5]  
FRANK JS, 1989, J LIPID RES, V30, P967
[6]  
Grewal IS, 1997, J IMMUNOL, V159, P401
[7]   Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice [J].
Gu, L ;
Okada, Y ;
Clinton, SK ;
Gerard, C ;
Sukhova, GK ;
Libby, P ;
Rollins, BJ .
MOLECULAR CELL, 1998, 2 (02) :275-281
[8]   DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM [J].
HAVEL, RJ ;
EDER, HA ;
BRAGDON, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) :1345-1353
[9]   Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL [J].
Ishikawa, K ;
Navab, M ;
Leitinger, N ;
Fogelman, AM ;
Lusis, AJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (05) :1209-1216
[10]  
ISSEKUTZ TB, 1995, J IMMUNOL, V154, P6533